Edwards Lifesciences (EW), the heart treatment and valve replacement company, has also gone on sale with shares falling 16% year-to-date after the recent bear market rally.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.